PDA Liposome Sensor for Platelet Activation Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monitoring platelet activation are cumbersome, costly, and often require laboratory access, making it difficult to accurately assess platelet function in patients, particularly those on antiplatelet medications, which can lead to hazardous bleeding complications.
Innovation Solution
Development of a PDA-based microarray sensor device that uses antibodies specific for activated platelets, allowing for the detection of platelet activation in whole blood samples without the need for separation or pretreatment, utilizing polydiacetylene (PDA) liposomes conjugated to antibodies like 9F9, which changes fluorescence signal intensity in response to antiplatelet drug concentrations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional methods such as aggregometry, cytometry, or atomic force microscope are used to monitor platelet function, then measurement precision is improved, but device complexity and loss of time increase significantly
Solution Approach 1:
The patent replaces complex mechanical and electronic monitoring systems with a simple optical sensing system. The PDA liposome-based sensor detects platelet activation through optical signal changes (fluorescence intensity) when platelets bind to the sensor surface, eliminating the need for complex aggregometry equipment, cytometers, or atomic force microscopes while maintaining measurement precision
Solution Approach 2:
The patent extracts and isolates the essential detection function from complex monitoring systems. By using PDA liposomes with specific antibodies that bind to activated platelets, the system extracts only the necessary components (sensor surface, binding specificity, optical detection) to achieve accurate platelet activation monitoring without requiring elaborate experimental setups
2Measurement precision
If laboratory-based methods are used for platelet monitoring, then measurement precision is improved, but loss of time and ease of operation deteriorate
Solution Approach 1:
The PDA liposome sensor performs self-detection without requiring external laboratory equipment or complex operational procedures. The sensor automatically detects platelet activation through optical signal changes when blood samples are applied, eliminating the need for specialized laboratory instruments and reducing examination time while maintaining precision
Solution Approach 2:
The patent utilizes changes in optical parameters (fluorescence intensity) of the PDA liposome sensor to detect platelet activation. When platelets bind to the sensor surface, the optical properties of the PDA liposome change, providing a rapid and direct measurement that eliminates time-consuming laboratory procedures
3Reliability
If antiplatelet medication is administered to prevent blood clotting, then patient safety is improved, but object-affected harmful factors increase due to hazardous bleeding
Solution Approach 1:
The patent implements a feedback mechanism where the sensor continuously monitors platelet activation status in real-time. The optical signal changes detected by the PDA liposome provide immediate feedback on platelet function, allowing healthcare providers to adjust antiplatelet medication dosages to optimize patient safety while minimizing bleeding risks through data-driven decision-making
4Ease of operation
If standard dose of antiplatelet drugs is advised without monitoring, then ease of operation is improved, but reliability deteriorates due to lack of accurate monitoring
Solution Approach 1:
The patent employs a simple, disposable PDA liposome sensor that can be easily applied to blood samples without requiring expensive laboratory equipment. The sensor's simplicity maintains ease of operation while its specific optical detection capability provides reliable monitoring data, bridging the gap between operational simplicity and monitoring reliability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides a rapid, cost-effective, and accurate method for monitoring platelet activation, enabling healthcare providers to determine appropriate antiplatelet drug dosages and adjust treatments accordingly, improving patient safety by facilitating continuous monitoring.
Implementation Method 1
The fluorescence signal intensity inversely related to the amount of Tirofiban, an inhibitor of platelet activated coagulation, added to whole blood samples
Data Source
AI summary
Provided herein are compositions, systems, and methods for monitoring platelet activation. In particular, provided herein are sensor devices for measuring platelet activation and uses thereof.